These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 35597437)

  • 1. Precision medicine in cancer: A paradigm shift.
    Rosenquist R; Fröhling S; Stamatopoulos K
    Semin Cancer Biol; 2022 Sep; 84():1-2. PubMed ID: 35597437
    [No Abstract]   [Full Text] [Related]  

  • 2. Network-based cancer precision medicine: A new emerging paradigm.
    Tan A; Huang H; Zhang P; Li S
    Cancer Lett; 2019 Aug; 458():39-45. PubMed ID: 31125640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shifting to a Biomarker Paradigm Across Cancer Care.
    Mahon SM
    Clin J Oncol Nurs; 2020 Dec; 24(6):633-634. PubMed ID: 33216051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic lethality: a step forward for personalized medicine in cancer.
    Jariyal H; Weinberg F; Achreja A; Nagarath D; Srivastava A
    Drug Discov Today; 2020 Feb; 25(2):305-320. PubMed ID: 31811941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrative cancer genomics in the era of precision cancer medicine.
    Inazawa J; Miki Y; Nakamura Y
    J Hum Genet; 2021 Sep; 66(9):843. PubMed ID: 34429508
    [No Abstract]   [Full Text] [Related]  

  • 6. From personalized to precision cancer medicine.
    Baltagiannis EG; Kyrochristos ID; Ziogas DE; Goussia A; Mitsis M; Roukos DH
    Per Med; 2020 Jul; 17(4):245-250. PubMed ID: 32589113
    [No Abstract]   [Full Text] [Related]  

  • 7. 'Strategic' development of precision cancer medicine in the United States.
    Schilsky RL
    Mol Oncol; 2021 Jul; 15(7):1747-1749. PubMed ID: 34053185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is Personalized Medicine Here?
    Carneiro BA; Costa R; Taxter T; Chandra S; Chae YK; Cristofanilli M; Giles FJ
    Oncology (Williston Park); 2016 Apr; 30(4):293-303, 307. PubMed ID: 27085327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular profiling for personalized cancer care.
    Ashfaq R
    Clin Exp Metastasis; 2012 Oct; 29(7):653-5. PubMed ID: 22678423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding the Precision in "Precision Medicine".
    Chabner BA
    Oncologist; 2016 Sep; 21(9):1029-30. PubMed ID: 27566249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional precision cancer medicine-moving beyond pure genomics.
    Letai A
    Nat Med; 2017 Sep; 23(9):1028-1035. PubMed ID: 28886003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethical considerations of neuro-oncology trial design in the era of precision medicine.
    Gupta S; Smith TR; Broekman ML
    J Neurooncol; 2017 Aug; 134(1):1-7. PubMed ID: 28555425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lung cancer as a paradigm for precision oncology in solid tumours.
    Schallenberg S; Merkelbach-Bruse S; Buettner R
    Virchows Arch; 2017 Aug; 471(2):221-233. PubMed ID: 28730537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Precision medicine in oncology: Challenges, stakes and new paradigms].
    Cox S; Rousseau-Tsangaris M; Abou-Zeid N; Dalle S; Leurent P; Cutivet A; Le HH; Kotb S; Bogaert B; Gardette R; Baran Y; Holder JM; Lerner L; Blay JY; Cambrosio A; Tredan O; Denèfle P
    Bull Cancer; 2019 Feb; 106(2):97-104. PubMed ID: 30713005
    [No Abstract]   [Full Text] [Related]  

  • 15. Should next-generation sequencing tests be performed on all cancer patients?
    McKenzie AJ; H Dilks H; Jones SF; Burris H
    Expert Rev Mol Diagn; 2019 Feb; 19(2):89-93. PubMed ID: 30618301
    [No Abstract]   [Full Text] [Related]  

  • 16. A national precision cancer medicine implementation initiative for Norway.
    Taskén K; Russnes HEG; Aas E; Bjørge L; Blix ES; ; Enerly E; Fagereng GL; Flobak Å; Gilje B; Gjertsen BT; Guren TK; Heix J; Hovig E; Hovland R; ; ; Lønning PE; Meza-Zepeda LA; Mæhle PM; Nilsen HL; Thoresen SØ; Widerberg K; Smeland S; Helland Å
    Nat Med; 2022 May; 28(5):885-887. PubMed ID: 35513529
    [No Abstract]   [Full Text] [Related]  

  • 17. Personalized cancer medicine: are we there yet?
    Lawler M; Selby P
    Oncologist; 2013 Jun; 18(6):649-50. PubMed ID: 23814159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The paradox of precision medicine.
    Kimmelman J; Tannock I
    Nat Rev Clin Oncol; 2018 Jun; 15(6):341-342. PubMed ID: 29674669
    [No Abstract]   [Full Text] [Related]  

  • 19. Precision medicine for cancer patients: worth a special issue.
    Höffken K
    J Cancer Res Clin Oncol; 2023 Jan; 149(1):1. PubMed ID: 36637502
    [No Abstract]   [Full Text] [Related]  

  • 20. Precision oncology in patients with nonmetastatic disease: emerging reality or illusion.
    Antoniou P; Ziogas DE; Mitsis M; Roukos DH
    Future Oncol; 2019 Jun; 15(16):1805-1810. PubMed ID: 31170806
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.